Stevens Capital Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-8,071
| Closed | -$686K | – | 549 |
|
|
2019
Q4 | $686K | Buy |
+8,071
| New | +$538K | 0.06% | 288 |
|
|
2018
Q4 | – | Sell |
-13,222
| Closed | -$395K | – | 1022 |
|
|
2018
Q3 | $395K | Buy |
+13,222
| New | +$498K | 0.01% | 559 |
|
|
2018
Q1 | – | Sell |
-9,122
| Closed | -$249K | – | 1087 |
|
|
2017
Q4 | $249K | Buy |
9,122
+645
| +8% | +$19.9K | 0.01% | 700 |
|
|
2017
Q3 | $314K | Buy |
8,477
+996
| +13% | +$36.7K | 0.01% | 657 |
|
|
2017
Q2 | $284K | Buy |
+7,481
| New | +$333K | 0.01% | 693 |
|
|
2015
Q2 | – | Sell |
-7,504
| Closed | -$210K | – | 1329 |
|
|
2015
Q1 | $210K | Buy |
+7,504
| New | +$211K | 0.01% | 849 |
|
|
2014
Q4 | – | Sell |
-45,962
| Closed | -$1.03M | – | 1320 |
|
|
2014
Q3 | $1.03M | Buy |
+45,962
| New | +$1.17M | 0.03% | 446 |
|
|
2014
Q2 | – | Sell |
-36,996
| Closed | -$1.05M | – | 1398 |
|
|
2014
Q1 | $1.05M | Buy |
+36,996
| New | +$1.22M | 0.03% | 472 |
|
|
2013
Q3 | – | Sell |
-12,952
| Closed | -$398K | – | 1275 |
|
|
2013
Q2 | $398K | Buy |
+12,952
| New | +$433K | 0.01% | 638 |
|
Other funds holding MDCO
Stevens Capital Management's MDCO Position: Q1 2020 in Review
Stevens Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 8,071 shares — an estimated $686K sold.
Stevens Capital Management first reported a position in MDCO in Q2 2013 and held it in 9 quarters. The position peaked at $1.05M in Q1 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Stevens Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Stevens Capital Management sold 8,071 Medicines Co shares in Q1 2020, an estimated $686K.
- Stevens Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 9 quarters.
- Stevens Capital Management's Medicines Co position peaked at $1.05M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.